Client News
Filter by:
- Apr 29 2024 Zevra Therapeutics’ President and Chief Executive Officer Issues Letter to Stockholders Highlighting Recent Key Accomplishments and Outlook for 2024
- Apr 26 2024 Ideanomics Announces Receipt of Notice from Nasdaq Regarding Listing Rule 5250(f)
- Apr 25 2024 Elicio Therapeutics to Present New Preliminary Data from the Ongoing AMPLIFY-7P Phase 1/2 Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting
- Apr 25 2024 Valero Energy Reports First Quarter 2024 Results
- Apr 24 2024 Ideanomics Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
- Apr 22 2024 LuxUrban Hotels Appoints Andrew Schwartz to Board of Directors
- Apr 22 2024 LuxUrban Hotels Appoints Elan Blutinger Non-Executive Chairman of the Board of Directors
- Apr 18 2024 ASHFORD HOSPITALITY TRUST ANNOUNCES CEO SUCCESSION PLAN
- Apr 18 2024 Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
- Apr 18 2024 Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) and Investigator-Initiated Pre-Clinical Studies at European Society of Clinical Microbiology & Infectious Diseases Global (ESCMID Global) 2024